PillNystatin
Nystatin
17 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it17 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| ATLANTIC BIOLOGICALS CORP. | unknown | 9 | SUPPLYING |
| PAI Holdings, LLC dba PAI Pharma | unknown | 5 | SUPPLYING |
| Pharmaceutical Associates, Inc. | unknown | 5 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 3 | SUPPLYING |
| Kesin Pharma Corporation | unknown | 3 | SUPPLYING |
| Xttrium Laboratories, Inc. | unknown | 3 | SUPPLYING |
| Leading Pharma, LLC | unknown | 2 | SUPPLYING |
| Major Pharmaceuticals | unknown | 2 | SUPPLYING |
| A-S Medication Solutions | unknown | 2 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 2 | SUPPLYING |
| Chartwell RX, LLC | unknown | 2 | SUPPLYING |
| Genus Lifesciences | unknown | 2 | SUPPLYING |
| Kanchan Healthcare Inc | unknown | 1 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
+ 2 more labelers
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 29, 2021RECALLRecall (Class II): Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, Rx ONLY, packaged in a) 16 fl oz (473 mL…
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup. — Recalling firm: PAI Holdings, LLC. dba Pharmaceutical Associates Inc — Distributed Nationwide in the USA
- Aug 4, 2020RECALLRecall (Class II): Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceuti…
Subpotent drug: Out of specification for assay at the 15-month test interval. — Recalling firm: PAI Holdings, LLC. dba Pharmaceutical Associates Inc — Nationwide USA
- Mar 19, 2020RECALLRecall (Class II): Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai P…
SubPotent Drug: Low out-of-specification results for assay testing. — Recalling firm: PAI Holdings, LLC. dba Pharmaceutical Associates Inc — Nationwide in the USA.
- Jan 14, 2020RECALLRecall (Class II): Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceu…
Subpotent: Out of specification for assay at the 12-month time point. — Recalling firm: Pharmaceutical Associates Inc — Distributed Nationwide in the US
- May 29, 2018RECALLRecall (Class III): Nystatin Oral Suspension, USP, 500,000 units/5 mL, For Institutional Use Only, packaged in 5 mL cups, Rx Only, Pharmac…
Resuspension problems: Out of specification for appearance and resuspendability. — Recalling firm: Pharmaceutical Associates Inc — Nationwide